Can Diane-35 (cyproterone acetate/ethinyl estradiol) be taken continuously without a hormone‑free interval?

Can Diane-35 Be Taken Continuously?

Yes, Diane-35 can be taken continuously without a hormone-free interval, as it is a combined hormonal contraceptive (CHC) and the practice of continuous dosing is supported by established guidelines for all CHCs.

Rationale for Continuous Dosing

The U.S. Selected Practice Recommendations for Contraceptive Use explicitly defines continuous contraceptive use as "uninterrupted use of hormonal contraception without a hormone-free interval" and provides specific guidance for this approach 1. While these guidelines don't specifically name Diane-35, they apply to all combined hormonal contraceptives, which includes Diane-35 (cyproterone acetate 2mg/ethinyl estradiol 35mcg).

Key Considerations

Expected Bleeding Patterns

• Unscheduled spotting or bleeding is common during the first 3-6 months of continuous CHC use 1
• This bleeding is generally not harmful and decreases with continued use
• Counsel patients about these expected changes before initiating continuous dosing

Managing Breakthrough Bleeding

If breakthrough bleeding occurs and the patient desires treatment:

1. First, rule out underlying problems: inconsistent use, drug interactions, smoking, STDs, pregnancy, or new uterine pathology (polyps, fibroids) 1

2. If no underlying problem is found, consider a hormone-free interval of 3-4 consecutive days 1:

   • Do NOT use this approach during the first 21 days of continuous use
   • Do NOT use more than once per month (reduces contraceptive effectiveness)

3. If bleeding persists and is unacceptable to the patient, counsel on alternative methods 1

Clinical Context for Diane-35

Research demonstrates that Diane-35 has been successfully used for 9-30 cycles without interruption in patients with polycystic ovary syndrome (PCOS), totaling 688 continuous treatment cycles 2. Another study documented continuous use for 4-25 months without issues related to the continuous dosing regimen itself 3. These studies confirm the feasibility of extended continuous use.

Important Caveats

• While continuous dosing is feasible, Diane-35 is specifically indicated for moderate to severe acne and/or hirsutism in women of reproductive age 4, 5
• The primary indication is treatment of hyperandrogenic symptoms, not contraception alone
• Weigh the benefits against venous thromboembolic risk on an individual basis 4
• The 2013 EMA recommendation regarding CPA/EE's risk profile should inform prescribing decisions 6

Practical Algorithm

For patients requesting continuous Diane-35:

1. Confirm appropriate indication (moderate-severe acne/hirsutism related to androgen sensitivity)
2. Assess VTE risk factors
3. Counsel about expected breakthrough bleeding in first 3-6 months
4. Instruct to take pills daily without a hormone-free interval
5. If breakthrough bleeding occurs after 21 days and is bothersome:
   • Evaluate for underlying causes
   • Consider 3-4 day hormone-free interval (maximum once monthly)
6. Monitor response and adjust based on patient tolerance

The evidence supports continuous dosing of Diane-35 as a viable option when clinically appropriate, following the same principles established for all combined hormonal contraceptives 1.